ID

36669

Descrição

Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02053285

Link

https://clinicaltrials.gov/show/NCT02053285

Palavras-chave

Versões (1)
  1. 31/05/2019 31/05/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

31 de maio de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Non-small Cell Lung Cancer Stage III NCT02053285

Inglês

Eligibility Non-small Cell Lung Cancer Stage III NCT02053285

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients aged greater than 18 years with a diagnosis of stage iii non-small cell lung cancer.
Descrição

Age | Non-Small Cell Lung Carcinoma TNM clinical staging

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C3258246
planned treatment with either definitive chemoradiotherapy or preoperative chemoradiotherapy followed by surgical resection.
Descrição

Chemoradiotherapy Planned | Chemoradiotherapy Preoperative Planned | Excision Planned

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0436307
UMLS CUI [1,2]
C1301732
UMLS CUI [2,1]
C0436307
UMLS CUI [2,2]
C0445204
UMLS CUI [2,3]
C1301732
UMLS CUI [3,1]
C0728940
UMLS CUI [3,2]
C1301732
pet-ct study within 4 weeks of next available dect study.
Descrição

PET/CT Study | DECT Study

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1699633
UMLS CUI [1,2]
C2603343
UMLS CUI [2,1]
C4055114
UMLS CUI [2,2]
C2603343
patients must have measurable primary and nodal disease, defined by at least one lesion (primary and lymph node) greater than 1 cm.
Descrição

Measurable Disease Primary | Disorder of lymph node Primary | Primary lesion Size Quantity | Lymph node Primary lesion Size Quantity

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205225
UMLS CUI [2,1]
C0272394
UMLS CUI [2,2]
C0205225
UMLS CUI [3,1]
C1402294
UMLS CUI [3,2]
C0456389
UMLS CUI [3,3]
C1265611
UMLS CUI [4,1]
C0024204
UMLS CUI [4,2]
C1402294
UMLS CUI [4,3]
C0456389
UMLS CUI [4,4]
C1265611
kidney function sufficient to tolerate iodine-based ct contrast.
Descrição

Renal function | CT iodinated contrast dye

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2,1]
C0040405
UMLS CUI [2,2]
C0879373
no allergy to iodine-based contrast.
Descrição

Iodine contrast allergy Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4022917
UMLS CUI [1,2]
C0332197
ability to understand and the willingness to sign informed consent.
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
participants with a prior history of thoracic radiotherapy.
Descrição

Radiotherapy to thorax

Tipo de dados

boolean

Alias
UMLS CUI [1]
C4038705
participants may not be receiving any other study agents.
Descrição

Investigational New Drugs

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0013230
inability to tolerate ct contrast
Descrição

CT scan contrast Receive Unable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0742919
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
pregnant women are excluded from this study because radiotherapy has the potential for teratogenic or abortifacient effects. because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with radiotherapy, breastfeeding should be discontinued if the mother is treated with radiotherapy. these potential risks may also apply to other agents used in this study.
Descrição

Pregnancy | Breast Feeding To be stopped

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C1272691
Voltar ao início da página

Similar models

Eligibility Non-small Cell Lung Cancer Stage III NCT02053285

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-Small Cell Lung Carcinoma TNM clinical staging
Item
patients aged greater than 18 years with a diagnosis of stage iii non-small cell lung cancer.
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
Chemoradiotherapy Planned | Chemoradiotherapy Preoperative Planned | Excision Planned
Item
planned treatment with either definitive chemoradiotherapy or preoperative chemoradiotherapy followed by surgical resection.
boolean
C0436307 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0436307 (UMLS CUI [2,1])
C0445204 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
C0728940 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
PET/CT Study | DECT Study
Item
pet-ct study within 4 weeks of next available dect study.
boolean
C1699633 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
C4055114 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
Measurable Disease Primary | Disorder of lymph node Primary | Primary lesion Size Quantity | Lymph node Primary lesion Size Quantity
Item
patients must have measurable primary and nodal disease, defined by at least one lesion (primary and lymph node) greater than 1 cm.
boolean
C1513041 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0272394 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C1402294 (UMLS CUI [3,1])
C0456389 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0024204 (UMLS CUI [4,1])
C1402294 (UMLS CUI [4,2])
C0456389 (UMLS CUI [4,3])
C1265611 (UMLS CUI [4,4])
Renal function | CT iodinated contrast dye
Item
kidney function sufficient to tolerate iodine-based ct contrast.
boolean
C0232804 (UMLS CUI [1])
C0040405 (UMLS CUI [2,1])
C0879373 (UMLS CUI [2,2])
Iodine contrast allergy Absent
Item
no allergy to iodine-based contrast.
boolean
C4022917 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Informed Consent
Item
ability to understand and the willingness to sign informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Radiotherapy to thorax
Item
participants with a prior history of thoracic radiotherapy.
boolean
C4038705 (UMLS CUI [1])
Investigational New Drugs
Item
participants may not be receiving any other study agents.
boolean
C0013230 (UMLS CUI [1])
CT scan contrast Receive Unable
Item
inability to tolerate ct contrast
boolean
C0742919 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Pregnancy | Breast Feeding To be stopped
Item
pregnant women are excluded from this study because radiotherapy has the potential for teratogenic or abortifacient effects. because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with radiotherapy, breastfeeding should be discontinued if the mother is treated with radiotherapy. these potential risks may also apply to other agents used in this study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial